Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients With Acute Coronary Syndromes

Abstract

Use of combination evidence-based medical therapies was independently and strongly associated with lower 6-month mortality in patients with acute coronary syndromes. Such therapies, most of which are generic and inexpensive today, seem to offer a marked survival advantage compared with patients in whom such therapies are omitted.